Panagora Asset Management Inc Lineage Cell Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$0.71 - $1.18 $37,726 - $62,700	-53,136 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$0.6 - $1.58 $18,184 - $47,886	-30,308 Reduced 36.32%	53,136 $43,000
Q4 2019 Feb 12, 2020	SELL	$0.54 - $1.01 $99,815 - $186,692	-184,844 Reduced 68.9%	83,444 $69,000
Q3 2019 Nov 12, 2019	BUY	$0.85 - $1.24 $228,044 - $332,677	268,288 New	268,288 $262,000

121

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.